NCT01586052View on ClinicalTrials.gov

Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Cerebral Palsy
Interventions
DRUG

Erythropoietin

250 IU/kg, Twice a week for 4 weeks

Trial Locations (1)

463-712

CHA Bundang Medical Center, CHA University, Seongnam-si

Sponsors

Collaborators (1)

LG Life Sciences
All Listed Sponsors
collaborator

LG Life Sciences

INDUSTRY

lead

MinYoung Kim, M.D.

OTHER